Weitere Symbole
| # | Letzte 7 Tage | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 5723 | SCSB | 24.58 USD | -0.04% | +0.08% | -0.41% | -1.80% | 0 USD | ||
| 5724 | SCUB | 24.97 USD | 0.00% | +0.12% | +0.08% | -0.36% | 0 USD | ||
| 5725 | ABUF | 28.13 USD | +0.43% | +0.50% | +2.03% | +11.80% | 0 USD | ||
| 5726 | NASA | 23.57 USD | -2.16% | -6.69% | +3.92% | -2.12% | 0 USD | ||
| 5727 | NEXR | 0.98 USD | -2.97% | 0.00% | -36.77% | -55.66% | 0 USD | ||
| 5728 | ARKI Arkadia International | 23.48 USD | 0.00% | -1.30% | +3.21% | +17.40% | 0 USD | ||
| 5729 | ARLI | 25.73 USD | 0.00% | 0.00% | -1.94% | +2.51% | 0 USD | ||
| 5730 | CHNL | 29.65 USD | 0.00% | 0.00% | +12.91% | +42.34% | 0 USD | ||
| 5731 | CHNU | 33.10 USD | +1.04% | -15.19% | +20.94% | +59.06% | 0 USD | ||
| 5732 | CRDD | 18.54 USD | +3.11% | -11.71% | +15.80% | -8.85% | 0 USD | ||
| 5733 | CRDX | 12.80 USD | +5.09% | -18.21% | +22.96% | -39.91% | 0 USD | ||
| 5734 | DDFA | 20.70 USD | +0.15% | +0.39% | +1.17% | +7.81% | 0 USD | ||
| 5735 | DDTA | 21.08 USD | 0.00% | +0.48% | +1.49% | +10.14% | 0 USD | ||
| 5736 | DLUX | 49.90 USD | +0.08% | +0.22% | -0.48% | -0.32% | 0 USD | ||
| 5737 | CSHR | 4.43 USD | -5.14% | -9.59% | -2.85% | -50.67% | 0 USD | ||
| 5738 | HMH | 18.93 USD | -0.73% | -2.12% | -7.34% | +0.16% | 0 USD | ||
| 5739 | INDQ | 23.99 USD | 0.00% | 0.00% | -6.83% | -4.91% | 0 USD | ||
| 5740 | PZIV | 29.17 USD | -0.31% | -0.14% | -3.57% | +13.86% | 0 USD | ||
| 5741 | PZLV | 29.70 USD | 0.00% | 0.00% | -2.81% | +17.76% | 0 USD | ||
| 5742 | QBIF | 25.99 USD | +0.27% | -0.12% | -1.70% | +3.05% | 0 USD |
Nachrichten Weitere Symbole
Myomo ernennt Mary-Katherine McClure zur neuen Chief Commercial Officer
ArriVent: Erster Patient in Phase-1-Studie mit Krebsmedikament ARR-002 behandelt
Watsco übernimmt The Granite Group: BBH Capital Partners schließt Exit ab
Lattice Semiconductor stellt quantenresistente Sicherheitslösung vor
Cytokinetics: Neue Studiendaten untermauern Wirksamkeit von Aficamten
Syndax Pharmaceuticals: Aktie stürzt nach gescheiterter IPF-Studie ab
Syndax: Axatilimab verfehlt primären Endpunkt in Studie zu Lungenfibrose
Gainers Weitere Symbole
POAS Phaos Technology Holdings Limited Class A Ordinary Shares | 1.94 | +1285.71% |
WFF WF Holding Limited - Ordinary Shares | 25.23 | +105.29% |
SKYA | 2.61 | +43.41% |
ELOG Eastern International Ltd. - Ordinary Shares | 1.03 | +27.16% |
LITZ | 21.70 | +21.91% |
CBRZ | 14.12 | +19.76% |
BEZ | 5.46 | +14.47% |
SMZ | 24.20 | +13.40% |
Losers Weitere Symbole
DKI DarkIris Inc. - Class A Ordinary Shares | 0.14 | -58.82% |
PSIG PS International Group Ltd. - Ordinary Shares | 3.41 | -33.14% |
BGLWW Blue Gold Limited - Warrant | 0.0261 | -30.40% |
WCT Wellchange Holdings Company Limited - Class A Ordinary shares | 0.71 | -27.55% |
HDRN | 0.80 | -25.23% |
QUCY | 1.05 | -22.22% |
LITU | 20.94 | -21.92% |
CBRX | 5.33 | -21.04% |